Arrowhead Pharmaceuticals, Inc. (ARWR)
NASDAQ·Healthcare·Biotechnology
$47.80
-17.69%
Mkt Cap $8.22B
Analyst Ratings
Buy
14
Hold
0
Sell
0
Price Target (37 analysts)
$104.43
Range $46.00 – $126.00
Implied Upside
+118.5%
Consensus $104.43 vs current $47.80